Sterling Capital Management
PLSE icon

Sterling Capital Management’s Pulse Biosciences PLSE Stock Holding History

Sterling Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.7K Buy
614
+549
+845% +$23.2K ﹤0.01% 1978
2026
Q2 		$1.8K Sell
65
-50
-43% -$1.18K ﹤0.01% 3015
2026
Q1 		$2.48K Hold
115
– – ﹤0.01% 2945
2025
Q4 		$1.58K Buy
115
+72
+167% +$1.12K ﹤0.01% 3094
2025
Q3 		$761 Hold
43
– – ﹤0.01% 3115
2025
Q2 		$649 Buy
43
+24
+126% +$398 ﹤0.01% 3122
2025
Q1 		$306 Hold
19
– – ﹤0.01% 3036
2024
Q4 		$331 Hold
19
– – ﹤0.01% 3075
2024
Q3 		$333 Buy
+19
New +$324 ﹤0.01% 3007

Other funds holding PLSE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Griffin Asset Management
Griffin Asset Management New York $934M AUM 18.69% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Sterling Capital Management's PLSE Position: Q3 2026 in Review

Sterling Capital Management increased its Pulse Biosciences (PLSE) stake by 845% in Q3 2026, buying an estimated $23.2K and bringing the position to 614 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Sterling Capital Management first reported a position in PLSE in Q3 2024 and has held it in 9 quarters since. 48 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Sterling Capital Management held 614 shares of Pulse Biosciences worth $30.7K as of Q3 2026.
  • Sterling Capital Management bought 549 Pulse Biosciences shares in Q3 2026, an estimated $23.2K.
  • Pulse Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1978 holding.
  • Sterling Capital Management first reported a position in Pulse Biosciences in Q3 2024 and has held it in 9 quarters since.
  • 48 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.